Gait Characteristics Following a Fall

Neurological Conditions Clinical Trial

Official title:

Quantification of Gait Parameters and Muscle Activation Patterns Following a Fall

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01631604
• Other study ID #: Fall-HMO-CTIL
• Status: Active, not recruiting
• Phase: N/A
• First received: June 28, 2012
• Last updated: April 26, 2017
• Start date: June 2012
• Est. completion date: June 2017

Study information

• Verified date: June 2012
• Source: Hadassah Medical Organization
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to quantify the safety degree of the patient's gait, to detect the reason for the fall and quantify the biomechanical parameters related to fall. This study also aims to evaluate the effect of different rehabilitation treatments and their effect on the risk of falling.

Description:

In this study, patients suffering from motor disabilities as a result of orthopedic or neurologic impairments will be tested at the gait and motion laboratory. Each patient will be secured with a ceiling-mounted safety harness and will walk on the path wearing passive light-reflecting markers and surface electrodes. High-speed cameras will record the subject's movements and the markers will be tracked to produce data of joint angles, velocities and accelerations. Dynamic EMG will be recorded from various muscles.

During the examination, the gait of the subjects will be disturb by either (i) a visual or sound signal that requires the subject to stop immediately, or (ii) walking different terrains, or (iii) tying a string to the foot and pulling it shortly to induce a trip.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 0
• Est. completion date: June 2017
• Est. primary completion date: June 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 5 Years and older

Eligibility

Inclusion Criteria:

• Individuals suffering from gait impairment following injury to the central or peripheral nervous system, as well as following orthopedic injuries. The subjects will be able to understand and independently sign a consent form.

Exclusion Criteria:

• Subjects who are unable to understand and independently sign a consent form

• Subjects who are wheelchair bound.

• Pregnant women.

Related Conditions & MeSH terms

• Motor Impairments
• Neurological Conditions
• Orthopaedic Injuries

Intervention

Device:
• Walking aids and devices
Walking aids, e.g. braces, canes,orthoses, prosthetics, etc.

Drug:
• Muscle/nerve injection
Injection to muscle or nerve

Procedure:
• Corrective surgery
correction of spinal and bony deformities, muscle transfer, tendon elongation etc.

Other:
• Physical therapy treatment

Locations

Country	Name	City	State
Israel	Hadassah Medical Center	Jerusalem

Sponsors (1)

Lead Sponsor	Collaborator
Hadassah Medical Organization

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Gait kinematics	Joint angles, velocities and accelerations
Secondary	Muscle activation patterns	Dynamic EMG of various muscles.